BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World
Pfizer has opened an extension to its active pharmaceutical ingredient (API) plant in Singapore. The SGD $1 billion ($743 million) facility covers 429,000 square feet and will produce antibiotics and small molecules to treat cancer and pain, the company said.
After making major manufacturing outlays in places like China and the United States earlier this year, Novo Nordisk is returning to its Danish roots.
Capra Biosciences to demonstrate biochemical production of pharmaceutical ingredient manufacturing at scale
Shilpa Medicare Limited's 100% subsidiary, Shilpa Pharma Lifesciences Limited's Active Pharmaceutical Ingredient (API) manufacturing facility, Unit II, situated at Raichur in Karnataka state has undergone a GMP inspection by ANVISA-Brazil from April 15-April 19, 2024.
Eurofins CDMO Alphora Inc. (Canada) Announces Completion of New API Manufacturing Facility
CPHI & PMEC China 2024 Ended Successfully
PITTSBURGH, July 3, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has closed the divestiture of its Over-the-Counter (OTC) business to Cooper Consumer Health, a leading European over-the-counter drug manufacturer and distributor, bringing to substantial completion all previously announced divestitures.
June 2024 — Porton J-STAR today announced that Enabling Technologies Consortium (ETC) has awarded a two-year contract to J-STAR to collaborate on “Co-processing Platform Technology.”